Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 1515)
Posted On: 05/09/2020 2:42:56 PM
Post# of 154022
Posted By: Nt2innvovate
Searching you nailed it. Doctors who treat patients with HCQ like Misiu and myself are well aware about side effects and patient access for Lupus and RA as well as what will happen if they miss a few weeks worth. We don't need lectures from a message board and Cuomo. All the docs I know are taking it or giving to their families when they get CV. That says more than anything else.


It's interesting that HCQ SHOWS SIMILAR EFFICACY TO REMDESIVIR IN VITRO, HAS 60 YEARS OF SAFETY DATA, IS FDA APPROVED, IS ORALLY DOSED, AND COSTS $4. So why wasn't the controlled trial run for HCQ at the same time as Rem? Maybe it doesn't work but where is the quality data either way. What was the rationale for not running the trial at the same time? The feds have 29 mil doses donated from Novartis ready to deploy. Does this make sense to anyone?














(4)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site